Stock Market

Biotech Firm Quince Therapeutics Repays Debt, Stock Rises Sharply

By Bullbit Editorial · March 30, 2026

• WhatQuince Therapeutics has repaid its $16M EIB debt
• WhyThe successful debt repayment has boosted investor confidence
• SignalShares surged 18% in response to the news
• TargetThe company's stock price is now more attractive to investors
• RiskThe market may be overvaluing the company's prospects

More breaking news →